Fact CheckerSign in

NCT05788848CompletedPhase 1

Virtual Reality Cognitive Therapy for Alzheimer's Disease

Source: ClinicalTrials.gov · Last updated 30 Dec 2024

Brief summary (registry, in English)

To evaluate the usability, feasibility, and acceptability of VRCT iteratively on 36 AD/ADRD individuals with mild to moderate CI.

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
36 (actual)
First submitted
15 Mar 2023
Start date
31 Mar 2023
Primary completion date
20 Aug 2024
Lead sponsor
Claritytek, Inc.
NCT number
NCT05788848

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 36
  • From 31 Mar 2023 to the primary completion date, 20 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of seizure disorder, vertigo disorder, or severe motion sickness that would impact their ability to participate in the intervention
  • History of any other serious condition that may limit their ability to participate in the intervention, as determined by the investigators.
  • Inability to use the VR device (e.g., severe visual/hearing impairment, aphasia, facial injuries)

Other

  • Non-English speaking

Who the study is looking for

  • Diagnosis of mild cognitive impairment (MCI), probable Alzheimer's disease (AD) or Alzheimer's disease Related Dementias (ADRD)
  • Montreal Cognitive Assessment (MoCA) score of 11-25
  • Age 30-89

Age in the registry: 30 years to 89 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
HealthPartners
Coordinator of this site? Confirm its status
Saint PaulUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.